Roblee P. Allen

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

Aaron B. Waxman, Ricardo Restrepo‐Jaramillo, Thenappan Thenappan et al. · New England Journal of Medicine · 2021 · 556 citations · Full text

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study)

Victor F. Tapson, Fernando Torres, F. Kermeen et al. · CHEST Journal · 2012 · 374 citations

Freedom-c Study, Hypertension, Pulmonary Arterial Hypertension +11

Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension

Zhi‐Cheng Jing, Keyur Parikh, Tomás Pulido et al. · Circulation · 2013 · 316 citations · Full text

Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry

Kevin Y. Chang, Sue Duval, David B. Badesch et al. · Journal of the American Heart Association · 2022 · 212 citations · Full text

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

Marius M. Hoeper, Hikmet Al‐Hiti, Raymond L. Benza et al. · The Lancet Respiratory Medicine · 2021 · 151 citations

Hypertension, Pulmonary Arterial Hypertension, Phosphodiesterase-5 Inhibitors +11